Johnson & Johnson plans to buy Dutch vaccine group
Friday, September 17, 2010 - 05:14
in Mathematics & Economics
US cosmetics and pharmaceutical giant Johnson & Johnson said on Friday it intended to acquire a Dutch vaccine maker Crucell which is active in developing countries for about 1.75 billion euros.